Pages that link to "Q43834028"
Jump to navigation
Jump to search
The following pages link to Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide (Q43834028):
Displaying 50 items.
- Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes (Q24642503) (← links)
- Glycemic control and hypoglycemia: is the loser the winner? (Q24645071) (← links)
- Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement (Q26783199) (← links)
- Exenatide once-weekly injection for the treatment of type 2 diabetes in Chinese patients: current perspectives (Q26797236) (← links)
- Diabetic kidney disease: a report from an ADA Consensus Conference (Q27012546) (← links)
- Individualising therapy for older adults with diabetes mellitus (Q28222223) (← links)
- Are hypoglycaemia and other adverse effects similar among sulphonylureas? (Q31122704) (← links)
- Hormonal counterregulation and consecutive glimepiride serum concentrations during severe hypoglycaemia associated with glimepiride therapy. (Q33430638) (← links)
- Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes (Q34073469) (← links)
- Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry (Q34449517) (← links)
- Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide (Q34480831) (← links)
- Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea. (Q34523733) (← links)
- Hypoglycaemia in Type 2 diabetes (Q34739954) (← links)
- Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes (Q34862358) (← links)
- Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials (Q35042504) (← links)
- Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines (Q35073384) (← links)
- A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy (Q35073584) (← links)
- Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience (Q35174221) (← links)
- Antidiabetic pharmacotherapy and anamnestic hypoglycemia in a large cohort of type 2 diabetic patients--an analysis of the DiaRegis registry (Q35183113) (← links)
- Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals (Q35533439) (← links)
- Hypoglycemia as a barrier to glycemic control (Q35690608) (← links)
- Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride (Q35783714) (← links)
- Xiaoke Pill () and anti-diabetic drugs: A review on clinical evidence of possible herb-drug interactions (Q35908631) (← links)
- The management of type 2 diabetic patients with hypoglycemic agents (Q35909101) (← links)
- Management of Hyperglycemia in Diabetic Kidney Disease (Q35953856) (← links)
- Glimepiride: evidence-based facts, trends, and observations (GIFTS). [corrected] (Q36251583) (← links)
- Insulin secretagogues: who, what, when, and how? (Q36269658) (← links)
- Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. (Q36519973) (← links)
- Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure? (Q36678584) (← links)
- Utilization study of antidiabetic agents in a teaching hospital of Sikkim and adherence to current standard treatment guidelines. (Q37058172) (← links)
- Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study (Q37101608) (← links)
- Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes (Q37102861) (← links)
- Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum (Q37517909) (← links)
- The treatment of type 2 diabetes (Q37634244) (← links)
- The role of glimepiride in the treatment of type 2 diabetes mellitus (Q37670198) (← links)
- Disorders of glucose metabolism–post mortem analyses in forensic cases: part I (Q37794021) (← links)
- Incretin Therapies in the Management of Elderly Patients with Type 2 Diabetes Mellitus (Q37858364) (← links)
- Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review (Q37888723) (← links)
- Incretin therapies in the management of patients with type 2 diabetes mellitus and renal impairment (Q38012068) (← links)
- Impact of the sitagliptin alert on prescription of oral antihyperglycemic drugs in Japan (Q38039957) (← links)
- Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors (Q38071007) (← links)
- Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease (Q38086611) (← links)
- The older patient with diabetes: a practical approach (Q38152414) (← links)
- Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies (Q38442816) (← links)
- Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes (Q38524435) (← links)
- Sulfonylureas and their use in clinical practice. (Q38577058) (← links)
- Comparative review of dipeptidyl peptidase-4 inhibitors and sulphonylureas. (Q38644587) (← links)
- Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease (Q38688345) (← links)
- Hypoglycaemia when adding sulphonylurea to metformin: a systematic review and network meta-analysis. (Q38899869) (← links)
- Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus (Q41124412) (← links)